New cancer drug enters first human testing
Disease control
Completed
This was the first-ever study in people of an experimental drug called WTX-330, designed to treat advanced cancers that have spread or stopped responding to standard treatments. The small trial enrolled 25 adults with advanced solid tumors or lymphoma to find a safe dose and see …
Phase: PHASE1 • Sponsor: Werewolf Therapeutics, Inc. • Aim: Disease control
Last updated Mar 17, 2026 13:10 UTC